French biotechnology company bioMérieux will expand and relocate its Philadelphia operation to a new building nearing completion in the Philadelphia Navy Yard. The company signed the first lease in 1201 Normandy Place, a four-story, 137,000-square-foot life science building being developed by Ensemble Real Estate Investments and Mosaic Development Partners in partnership with Oxford Properties.
French Biotechnology Firm Becomes First Tenant in New Life Science Building
bioMérieux, Inc. Leases 32,000 Square Feet at Navy Yard's 1201 Normandy Place
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Properties
- Iovance Biotherapeutics
300 Rouse Blvd, Philadelphia, PA
- ADAPTIMMUNE
351 Rouse Blvd, Philadelphia, PA
- WuXi AppTec
400 Rouse Blvd, Philadelphia, PA
- Companies
- Mosaic Development Partners
Construction
- Oxford Properties Group
Real Estate
- Contacts
- Matthew Knowles
First Vice President, CBRE